Cigna Corporation

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Cigna Group $CI Shares Sold by Allspring Global Investments Holdings ...

AI-generated analysis

πŸ“‰ Allspring Global Investments Holdings LLC reduced its CI stake by 66.3% in Q1, selling 185,718 shares to retain a position valued at $25.3 million.

πŸ“ˆ Several other institutional investors increased their stakes in Q4, including apricus wealth LLC (+715.9%) and OFI Invest Asset Management (+8,357.8%).

πŸ’° Cigna Group reported Q1 EPS of $7.79, beating the consensus estimate of $7.60, with revenue reaching $68.52 billion.

πŸ“Š Revenue grew 4.6% year-over-year to $68.52 billion, demonstrating solid top-line growth for the health services provider.

πŸ’΅ The company declared a quarterly dividend of $1.56 per share, paid on June 18th with an annualized yield of 2.2%.

πŸ“‰ Barclays downgraded CI from 'overweight' to 'equal weight' and lowered its price target from $310 to $304.

🎯 Raymond James Financial set a $340 price target, while Sanford C. Bernstein raised its target to $381 with an 'outperform' rating.

πŸ‘” CEO David Cordani sold 201,878 shares worth approximately $59.1 million under a pre-arranged Rule 10b5-1 trading plan.

πŸ“‰ CAO Jamie Kates sold 899 shares for a total transaction value of $268,450.39 on June 12th.

🏦 Cigna Group maintains a market cap of $75.13 billion with a P/E ratio of 12.04 and a debt-to-equity ratio of 0.69.

Bullish Signals
  • Cigna Group beat quarterly earnings estimates, reporting $7.79 EPS compared to the consensus of $7.60.
  • Revenue increased by 4.6% year-over-year to reach $68.52 billion in the most recent quarter.
  • Sanford C. Bernstein raised its price target to $381 and assigned an 'outperform' rating on July 9th.
  • Raymond James Financial set a bullish $340.00 price target for the stock.
  • The company maintains a healthy dividend yield of 2.2% with a payout ratio of 26.45%.
  • Institutional ownership remains robust at 86.99%, indicating continued confidence from major funds despite Allspring's reduction.
Risk Factors
  • Barclys downgraded the stock from 'overweight' to 'equal weight' and lowered its price target from $310 to $304.
  • CEO David Cordani executed a significant sale of 201,878 shares worth over $59 million, reducing his personal ownership by 85.46%.
Full Analysis
Allspring Global Investments Holdings LLC significantly reduced its stake in Cigna Group (CI) by 66.3% in the first quarter, selling 185,718 shares and retaining a position worth approximately $25.3 million. While Allspring exited substantially, other institutional investors like apricus wealth LLC, Wealth Enhancement Advisory Services LLC, Nisa Investment Advisors LLC, OFI Invest Asset Management, and Nepsis Inc. increased their holdings in the fourth quarter, collectively maintaining high institutional ownership at 86.99%. Analyst sentiment remains mixed but generally positive regarding Cigna's financial performance. Raymond James Financial set a $340 target price, while Sanford C. Bernstein raised its target to $381 with an 'outperform' rating. Conversely, Barclays downgraded the stock from 'overweight' to 'equal weight' and lowered its price target to $304. The consensus rating is currently a 'Moderate Buy' with an average price target of $338.80. Cigna Group reported strong quarterly results for the quarter ended April 30, beating earnings estimates with $7.79 EPS and revenue of $68.52 billion, which was up 4.6% year-over-year. The company also declared a quarterly dividend of $1.56 per share, paid on June 18th to shareholders of record on June 4th, resulting in an annualized dividend yield of 2.2%. CEO David Cordani sold over $59 million in shares under a pre-arranged trading plan, while CAO Jamie Kates sold approximately $268,000 worth of stock. Financial metrics indicate a stable balance sheet with a debt-to-equity ratio of 0.69 and a market capitalization of $75.13 billion. The stock trades at a P/E ratio of 12.04 and has recently traded between a one-year low of $239.51 and a high of $315.47, currently hovering near its fifty-day moving average of $286.59.